Daxor Corporation has been awarded a $1.9M two-year contract from the U.S. Air Force to support the continued development of a novel fluorescent tracer and optical sensing technology into a next-generation point-of-care blood volume analyzer for military and civilian applications.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR:
- Daxor expands blood volume analysis in three new facilities
- Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide
- Daxor awarded $550K matching-fund extension from U.S. DHA
- Daxor’s BVA-100 blood volume diagnostic expands to three new centers
- Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting